Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis. - Wikidata - awgldk - TriplyDB

Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.

Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q38165914

about

Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation Androgen Receptor: A Complex Therapeutic Target for Breast Cancer Sustained proliferation in cancer: Mechanisms and novel therapeutic targets Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies.Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes Androgen Receptor as a Potential Target for Treatment of Breast Cancer.Importance of Breast Cancer Subtype in the Development of Androgen Receptor Directed Therapy.Characterizing Breast Cancer in a Population with Increased Prevalence of Triple-Negative Breast Cancer: Androgen Receptor and ALDH1 Expression in Ghanaian Women Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.Pathological features of triple-negative breast cancers that showed progressive disease during neoadjuvant chemotherapy Prevalence and predictors of androgen receptor and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer.Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants.Androgen receptor (AR) expression in 400 breast carcinomas: is routine AR assessment justified?Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status The CYP17A1 inhibitor abiraterone exhibits estrogen receptor agonist activity in breast cancer.Proteomic-coupled-network analysis of T877A-androgen receptor interactomes can predict clinical prostate cancer outcomes between White (non-Hispanic) and African-American groups A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland.Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptor.NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas.Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients Prognostic significance of AMPK in human malignancies: A meta-analysis.Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma.Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer.Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer BRCA1 inhibits AR-mediated proliferation of breast cancer cells through the activation of SIRT1 Emerging therapeutic targets in metastatic progression: A focus on breast cancer.Pan-cancer analyses of the nuclear receptor superfamily Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients.Androgen deprivation therapy sensitizes triple negative breast cancer cells to immune-mediated lysis through androgen receptor independent modulation of osteoprotegerin.The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer.Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status.Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis Role of the androgen receptor in triple-negative breast cancer.AR-Signaling in Human Malignancies: Prostate Cancer and Beyond.Differential microRNA expression is associated with androgen receptor expression in breast cancer Integrative miRNA and mRNA analysis in penile carcinomas reveals markers and pathways with potential clinical impact.AR Signaling in Breast Cancer.

P2860

Q26770051-769356DC-0A11-49F6-92B1-6072160A1029 Q28075188-1D249DBD-B9B2-41AB-99DB-FDD2A1CD76AE Q28396388-63A37C41-821D-4BE9-97C3-FAC03B2EDC3C Q33591876-3A2A9FAA-EF7B-44FF-BFE1-546B26F8B94E Q33608593-46ACDC57-99AD-425C-8DAD-BF795BEF8B28 Q33625672-38D2A04E-1A1E-48B4-BA22-36BB7F689C23 Q33632582-ACE68118-55D6-43CC-A1E1-9B49A02D89D0 Q33697429-1B4A2997-03E9-4AB1-ADB9-3216D7B14798 Q33728381-9E0B35AF-7B99-473B-A26C-5AA1E927E2FA Q33873330-8C61C42E-BDD2-4F5E-9245-0BF39614ECCA Q33915040-DCEEEF27-4CF9-4238-BECD-3707E60412CF Q33915057-124DD9BD-BD64-481D-A1EE-8E25CAAB8130 Q33932665-F7FD6106-DB9C-4C17-96B3-569729B1E6F3 Q34043711-5767D29C-2DC6-45DE-9731-FA98F536CE19 Q34522279-3430474F-777C-4465-A14D-15FB8D7CD634 Q34542337-4D5DCE31-0DE6-47E8-B922-0073A41FF01B Q34550256-C163918A-37EC-46B3-B4D2-238559C36E92 Q34720998-45944EE4-D172-4557-9615-F746101A87E2 Q34995243-4BC5DB86-2CA7-4650-ABB0-EA2652827CF4 Q35155656-009A93A9-440A-4A27-90AC-FBD35D5743F9 Q35651216-2C040102-DA6B-4E8C-8AB3-BD8CE0BC71A3 Q36157437-C1E3A350-2580-4669-8FAB-0BB40F2A165C Q36295045-09635417-8527-4C32-8635-3183E47AB9D2 Q36331426-A3C02DFE-29E7-4039-8A26-FC9A5BB5C94E Q36547919-F4A73C6F-9560-444D-BA9D-652A1986F7C9 Q36605853-E7024F9A-6339-4B3D-BD6F-FE1C8B647B3B Q36854062-4BDF9308-5FA0-4E65-875A-5B5230D2D4F2 Q36907762-91A3A630-666F-4BD3-B6B3-AC4FD12D7576 Q36908403-A406584B-4D46-4EDD-ADA0-CFB5A3B2A786 Q37022250-129CF9A2-0A43-43FC-A400-3C1C870A2DDE Q37228018-4DC59B07-1FDC-40FC-B39F-D156174BAE3C Q37269053-A1AE0F06-A689-4A76-BC3C-7DD49EC66004 Q37513919-5E79A66E-F39D-4130-B786-AB4083F8AA7A Q37520209-0A340A65-72A2-45EA-85C7-AC11D47045B8 Q37564779-77C4CF36-2C37-4A4F-9412-2B498A8E03D9 Q37573317-A439D9EA-7E66-4CD8-80FE-EE340D48D97D Q37629545-09C600E1-D251-42BA-8036-9B6FD575950A Q37707636-7886D70D-920F-4955-B06B-8A442F489768 Q37716542-DE68FF5C-A917-480F-B762-9E6A42C5DD23 Q37721492-8335D72C-4789-4A1D-84C0-3822A80F86E8

P2860

Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q38165914

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Androgen receptor expression a ...... atic review and meta-analysis.

@en

type

label

Androgen receptor expression a ...... atic review and meta-analysis.

@en

prefLabel

Androgen receptor expression a ...... atic review and meta-analysis.

@en

P1433

Q38165914-2A1B909D-0553-4920-BE1C-BACB61D93821

P1476

Q38165914-2F359A06-06DE-4E2B-92B0-108D81E07766

P2093

Q38165914-4F62601B-AFC4-47D6-8296-25207F62040A

Q38165914-75B98C67-04C4-421F-8CCE-1EAE56E05DD7

Q38165914-7FC80C6B-AD1B-4661-952F-0DC8DB3295EA

Q38165914-8461069B-8B04-4E0A-8F4D-0D22F6140BD0

Q38165914-869B340E-E460-4B2F-AB47-BAAC52F08D47

Q38165914-B7CF923F-5537-4C92-AF82-780E608B59EB

Q38165914-B95074CE-7F91-4295-9968-80DA77DA2872

P2860

Q38165914-1C2FA46C-EF75-44B8-8B50-B432F66C2840

Q38165914-203E69AE-1E5E-4CA8-9AA1-415B5562270F

Q38165914-23FC5376-BF6F-40B7-9597-A55C621C26BA

Q38165914-2A242C54-073C-40CE-8641-F7ED20D74508

Q38165914-33C1BD65-B2E0-46AD-A121-5743614A5F75

Q38165914-40BFDE67-3896-4ECE-B088-8F0BE86EA702

Q38165914-46BA783E-EC98-4D36-97D6-21BE046A0B94

Q38165914-58CEB939-952E-4C53-B2B3-DBF97BC5FEB5

Q38165914-6B742E86-F8E5-4011-8154-D58F7452665D

Q38165914-6C764022-D11D-4608-A9BD-533DF2BA9406

P304

Q38165914-6782FC22-F310-4060-8FC0-0F50BA7191F8

P31

Q38165914-29845d8c-782b-45d3-aaa9-ac7b7838954f

Q38165914-4EF1C61D-DF85-4E15-9997-53996E0833ED

P356

Q38165914-790D72C4-A6B9-4EC3-A3D8-4A1D3A6ECE6F

P407

Q38165914-85E509FA-10B3-4CDE-B3F8-B83DB665D0F2

P433

Q38165914-BBFB4FDA-84D3-4F4C-A4D1-5135B6BAE89F

P478

Q38165914-A4BE0995-A8E1-437E-A4FA-848AD2EE4488

P50

Q38165914-9DD5624C-580E-4150-979F-50D255AC4115

Q38165914-AB42CBE5-3A59-4631-840B-361B09091EB3

Q38165914-DD48B28F-DDB5-4F30-B015-6B5EE6263DA5

P577

Q38165914-37913F82-2567-4F9E-9327-4E5DA5E25470

P5875

Q38165914-B257163C-3EEB-4E48-82AF-8ACF0CCED5D4

P698

Q38165914-E72CF633-2BCB-4C46-B6E2-DFF9A0B179CC

P356

P1433

Journal of the National Cancer Institute

P1476

Androgen receptor expression a ...... atic review and meta-analysis.

@en

P2093

Arnoud J Templeton

http://www.w3.org/2001/XMLSchema#string

Bostjan Seruga

http://www.w3.org/2001/XMLSchema#string

Francisco E Vera-Badillo

http://www.w3.org/2001/XMLSchema#string

Ian F Tannock

http://www.w3.org/2001/XMLSchema#string

Ivan Diaz-Padilla

http://www.w3.org/2001/XMLSchema#string

Mustafa Al-Mubarak

http://www.w3.org/2001/XMLSchema#string

Paulo de Gouveia

http://www.w3.org/2001/XMLSchema#string

P2860

Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer

Increased survival with enzalutamide in prostate cancer after chemotherapy

Abiraterone and increased survival in metastatic prostate cancer

Meta-analysis when only the median survival times are known: a comparison with individual patient data results.

c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.

Androgen receptor expression and breast cancer survival in postmenopausal women.

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells.

Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement

Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1.

Abnormal estrogen receptor in clinical breast cancer.

P304

djt319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJT319

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Philippe L. Bedard

P577

2013-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258856964

http://www.w3.org/2001/XMLSchema#string

P698

24273215

http://www.w3.org/2001/XMLSchema#string